APO Research
Talk to an analyst

APO RESEARCH · REPORT

Transthyretin

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Transthyretin Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

22 December 2025186 pages

Choose your research edition.

Industry ResearchTransthyretin Industry Research Report 2026117 pages · $2,950 USDIndustry Growth & TrendsGlobal Transthyretin Industry Growth and Trends Forecast to 203291 pages · $3,450 USDMarket StructureGlobal Transthyretin Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032186 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Transthyretin Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Transthyretin Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Transthyretin market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Transthyretin is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Transthyretin is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Transthyretin is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Transthyretin is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Transthyretin include Alnylam Pharmaceuticals Inc, Arcturus Therapeutics Inc, Ionis Pharmaceuticals Inc, Neurimmune Holding AG, Prothena Corp Plc, Regeneron Pharmaceuticals Inc and Pfizer Inc, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Transthyretin market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Transthyretin and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Transthyretin sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Transthyretin market size, projected growth trends, production technologies, key applications, and end-use industries.

Transthyretin Segment by Company

Alnylam Pharmaceuticals Inc

Arcturus Therapeutics Inc

Ionis Pharmaceuticals Inc

Neurimmune Holding AG

Prothena Corp Plc

Regeneron Pharmaceuticals Inc

Pfizer Inc

Transthyretin Segment by Type

AG-10

Inotersen Sodium

EDE-1307

CRX-1008

ALN-TTRsc02

Others

Transthyretin Segment by Application

Alzheimer's Disease

Familial Amyloid Neuropathies

Cardomyopathy

Neuropathy

Others

Transthyretin Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Transthyretin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Transthyretin and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Transthyretin.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Transthyretin market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Transthyretin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Transthyretin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Transthyretin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Transthyretin Industry Trends Table 2. Transthyretin Industry Drivers Table 3. Transthyretin Industry Opportunities and Challenges Table 4. Transthyretin Industry Restraints Table 5. Global Transthyretin Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Transthyretin Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Transthyretin Sales by Manufacturers (k units) & (2021-2026) Table 8. Global Transthyretin Sales Market Share by Manufacturers Table 9. Global Transthyretin Average Sales Price (US$/unit) of Manufacturers (2021-2026) Table 10. Global Transthyretin Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Transthyretin Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Transthyretin Manufacturers, Product Type & Application Table 13. Global Transthyretin Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Transthyretin by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of AG-10 Table 17. Major Manufacturers of Inotersen Sodium Table 18. Major Manufacturers of EDE-1307 Table 19. Major Manufacturers of CRX-1008 Table 20. Major Manufacturers of ALN-TTRsc02 Table 21. Major Manufacturers of Others Table 22. Global Transthyretin Sales by Type 2021 VS 2025 VS 2032 (k units) Table 23. Global Transthyretin Sales by Type (2021-2026) & (k units) Table 24. Global Transthyretin Sales by Type (2027-2032) & (k units) Table 25. Global Transthyretin Sales Market Share by Type (2021-2026) Table 26. Global Transthyretin Sales Market Share by Type (2027-2032) Table 27. Global Transthyretin Revenue by Type 2021 VS 2025 VS 2032 (k units) Table 28. Global Transthyretin Revenue by Type (2021-2026) & (k units) Table 29. Global Transthyretin Revenue by Type (2027-2032) & (k units) Table 30. Global Transthyretin Revenue Market Share by Type (2021-2026) Table 31. Global Transthyretin Revenue Market Share by Type (2027-2032) Table 32. Major Manufacturers of Alzheimer's Disease Table 33. Major Manufacturers of Familial Amyloid Neuropathies Table 34. Major Manufacturers of Cardomyopathy Table 35. Major Manufacturers of Neuropathy Table 36. Major Manufacturers of Others Table 37. Global Transthyretin Sales by Application 2021 VS 2025 VS 2032 (k units) Table 38. Global Transthyretin Sales by Application (2021-2026) & (k units) Table 39. Global Transthyretin Sales by Application (2027-2032) & (k units) Table 40. Global Transthyretin Sales Market Share by Application (2021-2026) Table 41. Global Transthyretin Sales Market Share by Application (2027-2032) Table 42. Global Transthyretin Revenue by Application 2021 VS 2025 VS 2032 (k units) Table 43. Global Transthyretin Revenue by Application (2021-2026) & (k units) Table 44. Global Transthyretin Revenue by Application (2027-2032) & (k units) Table 45. Global Transthyretin Revenue Market Share by Application (2021-2026) Table 46. Global Transthyretin Revenue Market Share by Application (2027-2032) Table 47. Global Transthyretin Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 48. Global Transthyretin Sales by Region (2021-2026) & (k units) Table 49. Global Transthyretin Sales Market Share by Region (2021-2026) Table 50. Global Transthyretin Sales Forecasted by Region (2027-2032) & (k units) Table 51. Global Transthyretin Sales Forecasted Market Share by Region (2027-2032) Table 52. North America Transthyretin Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 53. North America Transthyretin Sales by Country (2021-2026) & (k units) Table 54. North America Transthyretin Sales by Country (2027-2032) & (k units) Table 55. Europe Transthyretin Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 56. Europe Transthyretin Sales by Country (2021-2026) & (k units) Table 57. Europe Transthyretin Sales by Country (2027-2032) & (k units) Table 58. Asia Pacific Transthyretin Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 59. Asia Pacific Transthyretin Sales by Country (2021-2026) & (k units) Table 60. Asia Pacific Transthyretin Sales by Country (2027-2032) & (k units) Table 61. South America, Middle East and Africa Transthyretin Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 62. South America, Middle East and Africa Transthyretin Sales by Country (2021-2026) & (k units) Table 63. South America, Middle East and Africa Transthyretin Sales by Country (2027-2032) & (k units) Table 64. Global Transthyretin Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 65. Global Transthyretin Revenue by Region (2021-2026) & (US$ Million) Table 66. Global Transthyretin Revenue by Region (2027-2032) & (US$ Million) Table 67. Global Transthyretin Revenue Market Share by Region (2021-2026) Table 68. Global Transthyretin Revenue Market Share by Region (2027-2032) Table 69. Alnylam Pharmaceuticals Inc Company Information Table 70. Alnylam Pharmaceuticals Inc Business Overview Table 71. Alnylam Pharmaceuticals Inc Transthyretin Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Alnylam Pharmaceuticals Inc Transthyretin Product Portfolio Table 73. Alnylam Pharmaceuticals Inc Recent Development Table 74. Arcturus Therapeutics Inc Company Information Table 75. Arcturus Therapeutics Inc Business Overview Table 76. Arcturus Therapeutics Inc Transthyretin Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Arcturus Therapeutics Inc Transthyretin Product Portfolio Table 78. Arcturus Therapeutics Inc Recent Development Table 79. Ionis Pharmaceuticals Inc Company Information Table 80. Ionis Pharmaceuticals Inc Business Overview Table 81. Ionis Pharmaceuticals Inc Transthyretin Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. Ionis Pharmaceuticals Inc Transthyretin Product Portfolio Table 83. Ionis Pharmaceuticals Inc Recent Development Table 84. Neurimmune Holding AG Company Information Table 85. Neurimmune Holding AG Business Overview Table 86. Neurimmune Holding AG Transthyretin Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. Neurimmune Holding AG Transthyretin Product Portfolio Table 88. Neurimmune Holding AG Recent Development Table 89. Prothena Corp Plc Company Information Table 90. Prothena Corp Plc Business Overview Table 91. Prothena Corp Plc Transthyretin Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 92. Prothena Corp Plc Transthyretin Product Portfolio Table 93. Prothena Corp Plc Recent Development Table 94. Regeneron Pharmaceuticals Inc Company Information Table 95. Regeneron Pharmaceuticals Inc Business Overview Table 96. Regeneron Pharmaceuticals Inc Transthyretin Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 97. Regeneron Pharmaceuticals Inc Transthyretin Product Portfolio Table 98. Regeneron Pharmaceuticals Inc Recent Development Table 99. Pfizer Inc Company Information Table 100. Pfizer Inc Business Overview Table 101. Pfizer Inc Transthyretin Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 102. Pfizer Inc Transthyretin Product Portfolio Table 103. Pfizer Inc Recent Development Table 104. Key Raw Materials Table 105. Raw Materials Key Suppliers Table 106. Transthyretin Distributors List Table 107. Transthyretin Customers List Table 108. Research Programs/Design for This Report Table 109. Authors List of This Report Table 110. Secondary Sources Table 111. Primary Sources List of Figures Figure 1. Transthyretin Product Image Figure 2. Global Transthyretin Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Transthyretin Market Size (2021-2032) & (US$ Million) Figure 4. Global Transthyretin Sales (2021-2032) & (k units) Figure 5. Global Transthyretin Average Price (US$/unit) & (2021-2032) Figure 6. Global Top 5 and 10 Transthyretin Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. AG-10 Image Figure 9. Inotersen Sodium Image Figure 10. EDE-1307 Image Figure 11. CRX-1008 Image Figure 12. ALN-TTRsc02 Image Figure 13. Others Image Figure 14. Global Transthyretin Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 15. Global Transthyretin Sales Market Share 2021 VS 2025 VS 2032 Figure 16. Global Transthyretin Sales Market Share by Type (2021-2032) Figure 17. Global Transthyretin Revenue by Type (2021 VS 2025 VS 2032) & (k units) Figure 18. Global Transthyretin Revenue Market Share 2021 VS 2025 VS 2032 Figure 19. Global Transthyretin Revenue Market Share by Type (2021-2032) Figure 20. Alzheimer's Disease Image Figure 21. Familial Amyloid Neuropathies Image Figure 22. Cardomyopathy Image Figure 23. Neuropathy Image Figure 24. Others Image Figure 25. Global Transthyretin Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 26. Global Transthyretin Sales Market Share 2021 VS 2025 VS 2032 Figure 27. Global Transthyretin Sales Market Share by Application (2021-2032) Figure 28. Global Transthyretin Revenue by Application (2021 VS 2025 VS 2032) & (k units) Figure 29. Global Transthyretin Revenue Market Share 2021 VS 2025 VS 2032 Figure 30. Global Transthyretin Revenue Market Share by Application (2021-2032) Figure 31. North America Transthyretin Sales and Growth Rate (2021-2032) & (k units) Figure 32. North America Transthyretin Sales Market Share by Country (2021-2032) Figure 33. U.S. Transthyretin Sales and Growth Rate (2021-2032) & (k units) Figure 34. Canada Transthyretin Sales and Growth Rate (2021-2032) & (k units) Figure 35. Mexico Transthyretin Sales and Growth Rate (2021-2032) & (k units) Figure 36. Europe Transthyretin Sales and Growth Rate (2021-2032) & (k units) Figure 37. Europe Transthyretin Sales Market Share by Country (2021-2032) Figure 38. Germany Transthyretin Sales and Growth Rate (2021-2032) & (k units) Figure 39. France Transthyretin Sales and Growth Rate (2021-2032) & (k units) Figure 40. U.K. Transthyretin Sales and Growth Rate (2021-2032) & (k units) Figure 41. Italy Transthyretin Sales and Growth Rate (2021-2032) & (k units) Figure 42. Netherlands Transthyretin Sales and Growth Rate (2021-2032) & (k units) Figure 43. Asia Pacific Transthyretin Sales and Growth Rate (2021-2032) & (k units) Figure 44. Asia Pacific Transthyretin Sales Market Share by Country (2021-2032) Figure 45. China Transthyretin Sales and Growth Rate (2021-2032) & (k units) Figure 46. Japan Transthyretin Sales and Growth Rate (2021-2032) & (k units) Figure 47. South Korea Transthyretin Sales and Growth Rate (2021-2032) & (k units) Figure 48. Southeast Asia Transthyretin Sales and Growth Rate (2021-2032) & (k units) Figure 49. India Transthyretin Sales and Growth Rate (2021-2032) & (k units) Figure 50. Australia Transthyretin Sales and Growth Rate (2021-2032) & (k units) Figure 51. South America, Middle East and Africa Transthyretin Sales and Growth Rate (2021-2032) & (k units) Figure 52. South America, Middle East and Africa Transthyretin Sales Market Share by Country (2021-2032) Figure 53. Brazil Transthyretin Sales and Growth Rate (2021-2032) & (k units) Figure 54. South Africa Transthyretin Sales and Growth Rate (2021-2032) & (k units) Figure 55. Saudi Arabia Transthyretin Sales and Growth Rate (2021-2032) & (k units) Figure 56. Turkey Transthyretin Sales and Growth Rate (2021-2032) & (k units) Figure 57. Argentina Transthyretin Sales and Growth Rate (2021-2032) & (k units) Figure 58. UAE Transthyretin Sales and Growth Rate (2021-2032) & (k units) Figure 59. Egypt Transthyretin Sales and Growth Rate (2021-2032) & (k units) Figure 60. Chile Transthyretin Sales and Growth Rate (2021-2032) & (k units) Figure 61. Global Transthyretin Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Global Transthyretin Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 63. North America Transthyretin Revenue (2021-2032) & (US$ Million) Figure 64. North America Transthyretin Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Europe Transthyretin Revenue (2021-2032) & (US$ Million) Figure 66. Europe Transthyretin Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 67. Asia-Pacific Transthyretin Revenue (2021-2032) & (US$ Million) Figure 68. Asia-Pacific Transthyretin Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 69. South America, Middle East and Africa Transthyretin Revenue (2021-2032) & (US$ Million) Figure 70. South America, Middle East and Africa Transthyretin Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 71. Transthyretin Value Chain Figure 72. Manufacturing Cost Structure Figure 73. Transthyretin Production Mode & Process Figure 74. Direct Comparison with Distribution Share Figure 75. Distributors Profiles Figure 76. Years Considered Figure 77. Research Process Figure 78. Key Executives Interviewed

Scope & coverage.

Types
  • AG-10
  • Inotersen Sodium
  • EDE-1307
  • CRX-1008
  • ALN-TTRsc02
  • Others
Applications
  • Alzheimer's Disease
  • Familial Amyloid Neuropathies
  • Cardomyopathy
  • Neuropathy
  • Others
Companies covered
  • Alnylam Pharmaceuticals Inc
  • Arcturus Therapeutics Inc
  • Ionis Pharmaceuticals Inc
  • Neurimmune Holding AG
  • Prothena Corp Plc
  • Regeneron Pharmaceuticals Inc
  • Pfizer Inc

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Transthyretin Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Transthyretin Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Transthyretin Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Transthyretin Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Transthyretin Market Dynamics
  1. 2.1 Transthyretin Industry Trends
  2. 2.2 Transthyretin Industry Drivers
  3. 2.3 Transthyretin Industry Opportunities and Challenges
  4. 2.4 Transthyretin Industry Restraints
3 Transthyretin Market by Manufacturers
  1. 3.1 Global Transthyretin Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Transthyretin Sales by Manufacturers (2021-2026)
  3. 3.3 Global Transthyretin Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Transthyretin Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Transthyretin Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Transthyretin Manufacturers, Product Type & Application
  7. 3.7 Global Transthyretin Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Transthyretin Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Transthyretin Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Transthyretin Tier 1, Tier 2, and Tier 3
4 Transthyretin Market by Type
  1. 4.1 Transthyretin Type Introduction
  2. 4.1.1 AG-10
  3. 4.1.2 Inotersen Sodium
  4. 4.1.3 EDE-1307
  5. 4.1.4 CRX-1008
  6. 4.1.5 ALN-TTRsc02
  7. 4.1.6 Others
  8. 4.2 Global Transthyretin Sales by Type
  9. 4.2.1 Global Transthyretin Sales by Type (2021 VS 2025 VS 2032)
  10. 4.2.2 Global Transthyretin Sales by Type (2021-2032)
  11. 4.2.3 Global Transthyretin Sales Market Share by Type (2021-2032)
  12. 4.3 Global Transthyretin Revenue by Type
  13. 4.3.1 Global Transthyretin Revenue by Type (2021 VS 2025 VS 2032)
  14. 4.3.2 Global Transthyretin Revenue by Type (2021-2032)
  15. 4.3.3 Global Transthyretin Revenue Market Share by Type (2021-2032)
5 Transthyretin Market by Application
  1. 5.1 Transthyretin Application Introduction
  2. 5.1.1 Alzheimer's Disease
  3. 5.1.2 Familial Amyloid Neuropathies
  4. 5.1.3 Cardomyopathy
  5. 5.1.4 Neuropathy
  6. 5.1.5 Others
  7. 5.2 Global Transthyretin Sales by Application
  8. 5.2.1 Global Transthyretin Sales by Application (2021 VS 2025 VS 2032)
  9. 5.2.2 Global Transthyretin Sales by Application (2021-2032)
  10. 5.2.3 Global Transthyretin Sales Market Share by Application (2021-2032)
  11. 5.3 Global Transthyretin Revenue by Application
  12. 5.3.1 Global Transthyretin Revenue by Application (2021 VS 2025 VS 2032)
  13. 5.3.2 Global Transthyretin Revenue by Application (2021-2032)
  14. 5.3.3 Global Transthyretin Revenue Market Share by Application (2021-2032)
6 Global Transthyretin Sales by Region
  1. 6.1 Global Transthyretin Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Transthyretin Sales by Region (2021-2032)
  3. 6.2.1 Global Transthyretin Sales by Region (2021-2026)
  4. 6.2.2 Global Transthyretin Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Transthyretin Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Transthyretin Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Transthyretin Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Transthyretin Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Transthyretin Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Transthyretin Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Transthyretin Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Transthyretin Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Transthyretin Revenue by Region
  1. 7.1 Global Transthyretin Revenue by Region
  2. 7.1.1 Global Transthyretin Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Transthyretin Revenue by Region (2021-2026)
  4. 7.1.3 Global Transthyretin Revenue by Region (2027-2032)
  5. 7.1.4 Global Transthyretin Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Transthyretin Revenue (2021-2032)
  8. 7.2.2 North America Transthyretin Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Transthyretin Revenue (2021-2032)
  11. 7.3.2 Europe Transthyretin Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Transthyretin Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Transthyretin Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Transthyretin Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Transthyretin Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Alnylam Pharmaceuticals Inc
  2. 8.1.1 Alnylam Pharmaceuticals Inc Company Information
  3. 8.1.2 Alnylam Pharmaceuticals Inc Business Overview
  4. 8.1.3 Alnylam Pharmaceuticals Inc Transthyretin Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Alnylam Pharmaceuticals Inc Transthyretin Product Portfolio
  6. 8.1.5 Alnylam Pharmaceuticals Inc Recent Developments
  7. 8.2 Arcturus Therapeutics Inc
  8. 8.2.1 Arcturus Therapeutics Inc Company Information
  9. 8.2.2 Arcturus Therapeutics Inc Business Overview
  10. 8.2.3 Arcturus Therapeutics Inc Transthyretin Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Arcturus Therapeutics Inc Transthyretin Product Portfolio
  12. 8.2.5 Arcturus Therapeutics Inc Recent Developments
  13. 8.3 Ionis Pharmaceuticals Inc
  14. 8.3.1 Ionis Pharmaceuticals Inc Company Information
  15. 8.3.2 Ionis Pharmaceuticals Inc Business Overview
  16. 8.3.3 Ionis Pharmaceuticals Inc Transthyretin Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Ionis Pharmaceuticals Inc Transthyretin Product Portfolio
  18. 8.3.5 Ionis Pharmaceuticals Inc Recent Developments
  19. 8.4 Neurimmune Holding AG
  20. 8.4.1 Neurimmune Holding AG Company Information
  21. 8.4.2 Neurimmune Holding AG Business Overview
  22. 8.4.3 Neurimmune Holding AG Transthyretin Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Neurimmune Holding AG Transthyretin Product Portfolio
  24. 8.4.5 Neurimmune Holding AG Recent Developments
  25. 8.5 Prothena Corp Plc
  26. 8.5.1 Prothena Corp Plc Company Information
  27. 8.5.2 Prothena Corp Plc Business Overview
  28. 8.5.3 Prothena Corp Plc Transthyretin Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Prothena Corp Plc Transthyretin Product Portfolio
  30. 8.5.5 Prothena Corp Plc Recent Developments
  31. 8.6 Regeneron Pharmaceuticals Inc
  32. 8.6.1 Regeneron Pharmaceuticals Inc Company Information
  33. 8.6.2 Regeneron Pharmaceuticals Inc Business Overview
  34. 8.6.3 Regeneron Pharmaceuticals Inc Transthyretin Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Regeneron Pharmaceuticals Inc Transthyretin Product Portfolio
  36. 8.6.5 Regeneron Pharmaceuticals Inc Recent Developments
  37. 8.7 Pfizer Inc
  38. 8.7.1 Pfizer Inc Company Information
  39. 8.7.2 Pfizer Inc Business Overview
  40. 8.7.3 Pfizer Inc Transthyretin Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Pfizer Inc Transthyretin Product Portfolio
  42. 8.7.5 Pfizer Inc Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Transthyretin Value Chain Analysis
  2. 9.1.1 Transthyretin Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Transthyretin Production Mode & Process
  6. 9.2 Transthyretin Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Transthyretin Distributors
  9. 9.2.3 Transthyretin Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst